July 3, 2019 | RR Baliga, MD, MBA
This podcast discusses AHA/HFSA Scientific Statement on Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
April 4, 2019 | R.R. Baliga, MD, MBA, FACP, FRCP (Edin), FACC
Perspective: Given that more and more patients are on Factor Xa inhibitors, this study suggests that the safety and efficacy of andexanet (an inactive form of factor Xa which reverses the action of Factor Xa inhibitors) is promising. The results of an ongoing randomized trial are eagerly awaited.
March 5, 2019 | R.R. Baliga, MD, MBA
Push-up capacity is a no-cost, fast, and simple measure that may be a useful and objective clinical assessment tool for evaluating functional capacity and cardiovascular disease risk.